PTP
Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Yingjie Shen,1,*
Alan P. Tenney,1,*,
Sarah A. Busch,2
Kevin P. Horn,2
Fernando X. Cuascut,2
Kai Liu,3
Zhigang He,3
Jerry Silver,2
John G. Flanagan1,
Chondroitin sulfate proteoglycans (CSPGs) present a barrier
to axon regeneration. However, no specific receptor for the
inhibitory effect of CSPGs has been identified. We showed that
a transmembrane protein tyrosine phosphatase, PTP

, binds with
high affinity to neural CSPGs. Binding involves the chondroitin
sulfate chains and a specific site on the first immunoglobulin-like
domain of PTP

. In culture,
PTP
–/– neurons show reduced
inhibition by CSPG. A PTP

fusion protein probe can detect cognate
ligands that are up-regulated specifically at neural lesion
sites. After spinal cord injury,
PTP
gene disruption enhanced
the ability of axons to penetrate regions containing CSPG. These
results indicate that PTP

can act as a receptor for CSPGs and
may provide new therapeutic approaches to neural regeneration.
1 Department of Cell Biology and Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA.
2 Department of Neurosciences, Case Western Reserve University, Cleveland, OH 44106, USA.
3 Division of Neuroscience, Childrens Hospital, Harvard Medical School, Boston, MA 02115, USA.
* These authors contributed equally to this work.
Present address: Motor Neuron Center, Columbia University, New York, NY 10032, USA.
To whom correspondence should be addressed. E-mail: flanagan{at}hms.harvard.edu